Geron | GERN - Attività Correnti





Attività Correnti Cambiamento Data
Amgen USD 31.48B 2.42B 2026-03
Bio Techne USD 688.05M 50.62M 2026-03
Cassava Sciences USD 87.96M 9.74M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Geron USD 498.53M 21.74M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Incyte USD 5.48B 460.36M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03